Pharmacological approaches to managing migraine and associated comorbidities--clinical considerations for monotherapy versus polytherapy.
about
Migraine and its psychiatric comorbidities.Maternal characteristics and migraine pharmacotherapy during pregnancy: cross-sectional analysis of data from a large cohort study.Neurofeedback and biofeedback with 37 migraineurs: a clinical outcome study.Cerebral angiopathies as a cause of ischemic stroke in children: differential diagnosis and treatment options.Topiramate: safety and efficacy of its use in the prevention and treatment of migraine.Prophylaxis of migraine: general principles and patient acceptance.When should "chronic migraine" patients be considered "refractory" to pharmacological prophylaxis?Reflections and speculations on refractory migraine: why do some patients fail to improve with currently available therapies?Treatment recommendations for migraine.The effects of body mass index on the treatment of the patients with migraine headaches.Menstrual migraine: case studies of women with estrogen-related headaches.Migraine and psychiatric disorders: comorbidities, mechanisms, and clinical applications.The use of migraine preventive medications among patients with and without migraine headaches.Economic evaluation of pharmacotherapy of migraine pain: a review of the literature.OnabotulinumtoxinA effectiveness on chronic migraine, negative emotional states and sleep quality: a single-center prospective cohort study.Review of comorbidities and risk factors for the development of migraine complications (infarct and chronic migraine).δ-Opioid receptor agonists inhibit migraine-related hyperalgesia, aversive state and cortical spreading depression in mice.Comorbidity between migraine and depression: update on traditional and alternative treatments.Controversies in migraine: monotherapy.Polytherapy for migraine prophylaxis.Psychiatric comorbidities of episodic and chronic migraine.Refractory migraine - a review.Providing Care for Patients with Chronic Migraine: Diagnosis, Treatment, and Management.Traditional and alternative treatments for depression: implications for migraine management.The pharmacological treatment of migraine in Brazil.Fremanezumab as Add-On Treatment for Patients Treated With Other Migraine Preventive Medicines.Psychological and Behavioral Issues in the Management of Migraine in Children and Adolescents.Chronic Migraine: An Update on Physiology, Imaging, and the Mechanism of Action of Two Available Pharmacologic Therapies.Comparative effectiveness of onabotulinumtoxinA versus oral migraine prophylactic medications on headache-related resource utilization in the management of chronic migraine: Retrospective analysis of a US-based insurance claims database.Race, psychiatric comorbidity, and headache characteristics in patients in headache subspecialty treatment clinics.
P2860
Q30251982-A7FEFEE8-C310-4FFE-ACEC-185953FA7BB0Q33515892-480DC337-F083-468B-B438-FB3E017FF708Q33677659-6E96A626-0C84-4F1A-BC62-C54F8996E8C2Q33776803-A9F539A1-6C16-46DA-B649-F63A03BF0104Q36873926-C0533ADE-99B1-4623-A1CF-99212FBD8DDFQ37106958-B171EFD9-F433-4DC1-B5CE-C679C654BF2AQ37188633-19D659EE-047C-42FD-9817-F4C776B10B43Q37189724-A459ACB3-4705-4612-9BA7-A3A0147EC26FQ37229791-3DF6B6D6-2A09-4513-A0DD-E75F5CAA6CF5Q37311565-651D5AEC-A55F-4B05-B779-46DB7CCFC4EDQ37348700-272616E2-82CB-48CE-84A2-247B665E9037Q37470296-97152C13-3958-4B58-BAA5-EBD8E0C350B6Q37505125-009B2C9C-CFF0-4BDB-B53D-124B4FC31F5DQ37641349-BAFC0A6D-DE9A-4355-9374-B17B5390C17CQ37650532-B21CB434-8F79-488C-AB1B-AD35E2BEEE36Q37657614-0473D3F6-1267-47AE-90CF-9F856C03EE7EQ37719418-0B51C678-7576-4E48-B6E1-C68F362FD2BFQ37870779-EABEA2E6-2BED-4BF5-A283-1E8D321D2662Q38014300-36BD97C6-9EC3-4058-9ED4-B74FAC8808B8Q38014301-570DEE56-C140-4236-B772-9F148A5EEFF2Q38058242-2D2AC2D7-3EF4-4948-919A-A10848CE7B89Q38081178-09F3A3B4-EE8F-4C30-AFD3-7DB008A30271Q38255772-E25EDEFC-ED36-45B8-B6B2-BC5EE28FCE89Q38341758-96650DB1-472B-48D0-A87B-A4CF56AB93BEQ38346947-7B623AEE-0D4B-4409-80D5-293DEE6F9215Q38598006-81FEC8FE-1F26-4F3D-A48E-A8CBB79A9363Q39023201-2E41B13D-4F18-45CD-85C7-64CB1E6BE2C4Q39026796-6B7EA648-8180-4D25-9102-1F497AB44CC4Q40183047-0FEC3450-D4FD-41F6-8BCD-4B985E8BDCF3Q46705146-117E169B-11BE-470B-84BD-F4CC105474A5
P2860
Pharmacological approaches to managing migraine and associated comorbidities--clinical considerations for monotherapy versus polytherapy.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Pharmacological approaches to ...... onotherapy versus polytherapy.
@en
type
label
Pharmacological approaches to ...... onotherapy versus polytherapy.
@en
prefLabel
Pharmacological approaches to ...... onotherapy versus polytherapy.
@en
P2093
P2860
P50
P1433
P1476
Pharmacological approaches to ...... onotherapy versus polytherapy.
@en
P2093
Ann I Scher
Fred Freitag
Starr H Pearlman
Steven R Hahn
P2860
P304
P356
10.1111/J.1526-4610.2007.00760.X
P577
2007-04-01T00:00:00Z